Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Cogent Biosciences (COGT) Non Operating Income (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Non Operating Income data on record, last reported at $728000.0 in Q4 2021.

  • For Q4 2021, Non Operating Income rose 516.95% year-over-year to $728000.0; the TTM value through Dec 2021 reached $3.3 million, down 55.65%, while the annual FY2025 figure was -$20000.0, 100.1% down from the prior year.
  • Non Operating Income reached $728000.0 in Q4 2021 per COGT's latest filing, down from $735000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $7.2 million in Q3 2020 and bottomed at $10000.0 in Q2 2020.
  • Average Non Operating Income over 4 years is $764250.0, with a median of $204000.0 recorded in 2018.
  • The widest YoY moves for Non Operating Income: up 7330.0% in 2021, down 89.81% in 2021.
  • A 4-year view of Non Operating Income shows it stood at $398000.0 in 2018, then plummeted by 85.68% to $57000.0 in 2019, then soared by 107.02% to $118000.0 in 2020, then surged by 516.95% to $728000.0 in 2021.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $728000.0 in Q4 2021, $735000.0 in Q3 2021, and $743000.0 in Q2 2021.